Platelet Aspirin Resistance Detection and Validation

[...]because their definition of aspirin resistance has not been validated against clinical outcomes, it is arbitrary and thus must be viewed as speculative. (10), conclude that "nonadherence is a significant mediator of poor outcome ... and it is important to evaluate whether or not patients are taking their medications in clinical settings." [...]assays that ensure an antiplatelet effect may have great clinical value even in patient populations in whom, as reported by Tantry et al.